These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 25064846

  • 1. The multifaceted regulation and functions of PKM2 in tumor progression.
    Li Z, Yang P, Li Z.
    Biochim Biophys Acta; 2014 Dec; 1846(2):285-96. PubMed ID: 25064846
    [Abstract] [Full Text] [Related]

  • 2. PKM2 contributes to cancer metabolism.
    Wong N, Ojo D, Yan J, Tang D.
    Cancer Lett; 2015 Jan 28; 356(2 Pt A):184-91. PubMed ID: 24508027
    [Abstract] [Full Text] [Related]

  • 3. Dual roles of PKM2 in cancer metabolism.
    Wu S, Le H.
    Acta Biochim Biophys Sin (Shanghai); 2013 Jan 28; 45(1):27-35. PubMed ID: 23212076
    [Abstract] [Full Text] [Related]

  • 4. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
    He Y, Wang Y, Liu H, Xu X, He S, Tang J, Huang Y, Miao X, Wu Y, Wang Q, Cheng C.
    Leuk Res; 2015 Dec 28; 39(12):1428-36. PubMed ID: 26453405
    [Abstract] [Full Text] [Related]

  • 5. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
    Zheng S, Liu Q, Liu T, Lu X.
    J Physiol Biochem; 2021 Aug 28; 77(3):355-363. PubMed ID: 33835423
    [Abstract] [Full Text] [Related]

  • 6. Changes in PKM2 associate with prostate cancer progression.
    Wong N, Yan J, Ojo D, De Melo J, Cutz JC, Tang D.
    Cancer Invest; 2014 Aug 28; 32(7):330-8. PubMed ID: 24884829
    [Abstract] [Full Text] [Related]

  • 7. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
    Chen Z, Wang Z, Guo W, Zhang Z, Zhao F, Zhao Y, Jia D, Ding J, Wang H, Yao M, He X.
    Oncogene; 2015 Jul 23; 34(30):3946-56. PubMed ID: 25263439
    [Abstract] [Full Text] [Related]

  • 8. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S, Ji X, Wang R, Miao Y.
    Arch Gynecol Obstet; 2019 May 23; 299(5):1443-1451. PubMed ID: 30809696
    [Abstract] [Full Text] [Related]

  • 9. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
    Chaneton B, Gottlieb E.
    Trends Biochem Sci; 2012 Aug 23; 37(8):309-16. PubMed ID: 22626471
    [Abstract] [Full Text] [Related]

  • 10. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
    Amin S, Yang P, Li Z.
    Biochim Biophys Acta Rev Cancer; 2019 Apr 23; 1871(2):331-341. PubMed ID: 30826427
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma.
    Wang Y, Zhang X, Zhang Y, Zhu Y, Yuan C, Qi B, Zhang W, Wang D, Ding X, Wu H, Cheng J.
    Cancer Biol Ther; 2015 Apr 23; 16(6):839-45. PubMed ID: 25970228
    [Abstract] [Full Text] [Related]

  • 13. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
    Dando I, Cordani M, Donadelli M.
    IUBMB Life; 2016 Sep 23; 68(9):722-6. PubMed ID: 27385486
    [Abstract] [Full Text] [Related]

  • 14. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation.
    Li T, Han J, Jia L, Hu X, Chen L, Wang Y.
    Protein Cell; 2019 Aug 23; 10(8):583-594. PubMed ID: 30887444
    [Abstract] [Full Text] [Related]

  • 15. Structural insight into mechanisms for dynamic regulation of PKM2.
    Wang P, Sun C, Zhu T, Xu Y.
    Protein Cell; 2015 Apr 23; 6(4):275-287. PubMed ID: 25645022
    [Abstract] [Full Text] [Related]

  • 16. The role of PKM2 in cancer progression and its structural and biological basis.
    Wu B, Liang Z, Lan H, Teng X, Wang C.
    J Physiol Biochem; 2024 May 23; 80(2):261-275. PubMed ID: 38329688
    [Abstract] [Full Text] [Related]

  • 17. Moderate DNA damage promotes metabolic flux into PPP via PKM2 Y-105 phosphorylation: a feature that favours cancer cells.
    Kumar B, Bamezai RN.
    Mol Biol Rep; 2015 Aug 23; 42(8):1317-21. PubMed ID: 25840825
    [Abstract] [Full Text] [Related]

  • 18. [Metabolism enzyme controls cancer stemness].
    Konno M, Doki Y, Mori M, Ishii H.
    Nihon Rinsho; 2015 May 23; 73(5):745-50. PubMed ID: 25985625
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.